Clinical Trials Browser

OTHER × Interventional × BRCA1 Mutation × Clear all

NCT06177171 2026-02-02

Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

Phase 1 Recruiting

BRCA1 Mutation

NCT01630226 2012-07-12

Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland

Phase 2 Unknown

BRCA1 Mutation